Anatomic Pathology Market Trends

  • Report ID: 4377
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Anatomic Pathology Market Trends

Growth Drivers

  • Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.

  • Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were 21 292 active pathologists in June 2019 compared 12 839 anatomical and clinical pathologists in 2017.

  • Rising Prevalence of Chron’s disease – According to reports, every year 100 to 300 per 100,000 people suffer from Chron’s disease in North America and western Europe.
  • Growing Number of People Suffering from Kidney Disease –total number of people suffering from kidney disease is 850 million worldwide in 2021.

Challenges

  • High Expenditure Associated in Developing Anatomic Pathology
  • Non-availability of Refurbished Anatomic Pathology Equipment
  • Challenges in Transformation of Pathology Trends

Anatomic Pathology Market: Key Insights

Growth Drivers

  • Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.

  • Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were ~21 292 active pathologists in June 2019 compared ~12 839 anatomical and clinical pathologists in 2017.

  • Rising Prevalence of Chron’s disease – According to reports, every year ~100 to 300 per 100,000 people suffer from Chron’s disease in North America and western Europe.
  • Growing Number of People Suffering from Kidney Disease –total number of people suffering from kidney disease is ~850 million worldwide in 2021.

Challenges

  • High Expenditure Associated in Developing Anatomic Pathology
  • Non-availability of Refurbished Anatomic Pathology Equipment
  • Challenges in Transformation of Pathology Trends

The global anatomic pathology market is segmented and analyzed for demand and supply by type into services, consumables, and instruments. Amongst these segments, the services segment – 48.12% held the largest share in 2022, backed by the growing number of breast cancers along with the surge in the number of biopsies done worldwide. For instance, over 17 720 biopsies were recommended and performed, in between January 2019 to September 2020 in the United States.

Base Year

2024

Forecast Year

2025-2037

CAGR

8.4%

Base Year Market Size (2024)

USD 38.48 billion

Forecast Year Market Size (2037)

USD 108.01 bllion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4377
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anatomic pathology is evaluated at USD 41.1 billion.

The anatomic pathology market size was valued at USD 38.48 billion in 2024 and is anticipated to exceed USD 108.01 billion by the end of 2037, registering over 8.4% CAGR during the forecast period i.e., between 2025-2037. Increasing number of laboratory tests as well as biopsies performed along with rising cases of cancer, kidney diseases and others will propel the market growth.

North America industry will hold a share of 38% by 2037, backed by presence of a strong healthcare network in the region.

The major players in the market include PHC Holdings Corporation, Indica Labs, Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics Laboratories, Inc., Agilent Technologies, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample